Background {#Sec1}
==========

There is some initial evidence that an enhanced physical activity level can improve feelings of well-being, quality of life, and possibly survival among patients with lung cancer \[[@CR1]\]. In general the impact of exercise behaviors following a cancer diagnoses has been most extensively investigated for patients with breast and gastrointestinal malignancies \[[@CR2], [@CR3]\]. However, accruing evidence suggests that exercise behaviors may be an important and actionable determinant of lung cancer outcomes. The potential for a novel, non-toxic therapy warrants attention, since lung cancer, the most common cause of cancer death, has a tendency for late-stage diagnosis and, despite novel drug therapies, rapid, morbid, and inexorable progression \[[@CR4]\].

To date a range of both cross-sectional and longitudinal studies have examined associations between aerobic fitness and important outcomes at seminal points along the lung cancer trajectory. With few exceptions, investigators have characterized aerobic fitness at a single time point using maximal oxidative capacity (V0~2max~) or 6 min walk distance (6MWD). Cross sectional investigations have shown that aerobic fitness is associated with post-operative symptom burden and quality of life among patients with operable lung cancer \[[@CR5], [@CR6]\]. Longitudinal investigations have demonstrated that aerobic fitness predicts peri-operative complication rates for lung cancer surgeries, \[[@CR7]--[@CR9]\] as well as overall survival for both operable \[[@CR1]\] and inoperable \[[@CR10]\] lung cancer. Encouragingly, pilot studies have found exercise-based pulmonary rehabilitation programs, both pre- and post-operative, to be well tolerated and to enhance aerobic fitness \[[@CR9], [@CR11]--[@CR13]\]. Even patients with late stage lung cancer derive benefit from exercise training as manifest in improved a functional capacity and a reduced symptom burden \[[@CR14]--[@CR16]\].

Despite mounting evidence attesting the benefits of enhanced physical activity among lung cancer survivors, the longitudinal impact of shifting activity levels following a lung cancer diagnosis has yet to be examined using repeated measures. Our group previously reported that endorsement of regular physical activity among 272 long-term lung cancer survivors was associated with higher scores in overall QOL and all QOL sub-domains, as well as a reduced symptom burden \[[@CR26]\]. The primary aim of this project was to prospectively examine the relationship of physical activity level with quality of life and overall survival across multiple time points in a larger cohort of 1466 long-term lung cancer survivors. Secondary aims included examining the influence of treatment and demographic variables on these relationships and describing differences between survivors who did and did not characterize themselves as being physically active.

Methods {#Sec2}
=======

The Mayo Clinic Epidemiology and Genetics of Lung Cancer Research Program has enrolled and prospectively followed patients either diagnosed with and/or treated for lung cancer at Mayo Clinic, Rochester, Minnesota since its inception in 1997. Between January 1, 1997, and December 31, 2009, over 10,000 patients have been enrolled. Procedures for identifying and following lung cancer patients enrolled in this program have been previously described \[[@CR17]\]. Patient follow-up was accomplished by mailed questionnaire beginning at six months after diagnosis and annually thereafter.

Quality of life was assessed at all follow-up time points by means of one item from the Lung Cancer Symptom Scale (LCSS) \[[@CR18], [@CR19]\]. The overall QOL item served as the primary endpoint in the current study. In the primary analysis overall QOL is considered as a continuous variable, taking integer values from 0 to 100. Previously, The North Central Cancer treatment Group (NCCTG) Lung Cancer Committee compared alternative QOL assessments (the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire and Lung Cancer Module(EORTC-QLQ-LC13), the Functional Assessment of Cancer Therapy - Lung (FACT-L), and the Lung Cancer Symptom Scale(LCSS)) using a series of phase II clinical trials (NCCTG trials 95-20-53, 95-24-52, 96-24-51, 98-24-52). Ultimately it was found that the LCSS performed as well as the other two assessments and used fewer items to obtain the same information \[[@CR20]\]. A pooled analysis of lung cancer studies indicated that the single-item QOL assessments developed within the NCCTG were more sensitive to change than longer, multi-item assessments \[[@CR21]\]. This study also demonstrated that the relationship between QOL assessments and toxicity was modest at best and that clinically meaningful changes in QOL preceded adverse events captured by the Common Toxicity Criteria(CTC) by two to three months.

These single-item assessments have become the most-used assessment in all NCI-sponsored cancer control studies \[[@CR22]\] and have been validated extensively against more involved assessment processes \[[@CR23], [@CR24]\]. Normative data have been obtained from various clinical populations enrolled in NCCTG clinical trials and from healthy participants attending an NCCTG annual meeting. In assessing overall QOL on a 0--100 point scale, healthy volunteers will average about 82, hospice patients will average 78, advanced cancer patients will average somewhere between 60 and 75, newly diagnosed patients will average between 50 and 60. A score of 50 or below is indicative of a need for immediate exploration and intervention for the QOL deficit \[[@CR25]\]. This cutoff has been validated both by our research team \[[@CR21], [@CR26]\] and independently by others \[[@CR27]--[@CR29]\]. We recently published data indicating that these measures held prognostic power specifically among lung cancer patients \[[@CR30]\]. The NCCTG has included Linear Analog Scale Assessment(LASA) measures for overall QOL and fatigue in all phase II and phase III clinical trials since 2009 as an independent prognostic factor independent of performance status.

Self-reported physical activity and health promotion behaviors were provided by the lung cancer survivors using the modified Baecke questionnaire for physical activity \[[@CR31]\]. First developed for epidemiological studies of physical activity in a Dutch population \[[@CR32]\], the 16-item questionnaire consists of three subscales: 1) physical activity at work; 2) sport during leisure time; and 3) physical activity during leisure time excluding sport \[[@CR33]\]. It has been used in healthy, elderly, and chronic fatigue populations successfully \[[@CR34]--[@CR36]\]. Recent studies have idenitifed issues with its validity and reliability, but it remains the most often-used questionnaire for assessing physical activity in epidemiological studies \[[@CR37]\]. Specifically, it has been suggested that the Baecke questionnaire is best used to differentiate between active and inactive individuals rather than to differentiate active people into low and high activity level categories \[[@CR38]\].

The study sample included 1466 lung cancer survivors who completed the Baecke questionnaire at least once. The study sample used the first Baecke data recorded by each survivor to define the participant's physical activity level. We found little change over time in the Baecke scores (data not shown). By using the first observed Baecke scores, we acknowledge that the time since diagnosis and years studied will be variable. The scoring algorithm for the Baecke questionnaire was untenable because of a large amount of non-interpretable data. Our study team went through an extensive data cleaning operation wherein we made operational definitions and decisions as to how to record various eccentricities in the data. For example, patients provided multiple sports when asked for their primary sport activity, reported gambling as a sport, or provided Illogical combinations such as indicating they engaged in physical exercise during leisure time regularly for a total of zero minutes per day. As a result it became clear that we would only be able to present some subscale data and in reality could only analyze individual questions with confidence. The study protocol was reviewed and approved by the Mayo Clinic Institutional Review Board. Ethics approval of this study was granted by Mayo Clinic Institutional Review Board. Written informed consent was obtained from all participants.

Power considerations with 1466 lung cancer survivors, any percentage reported on the entire sample is accurate to within 2.6 with 95 % confidence. Any mean reported on such a sample is accurate to within 5 % times the standard deviation(SD) of the continuous variable's distribution, which is classified as a small effect size \[[@CR39]\]. For example, it is known that our overall QOL scores that range from 0--100 have a standard deviation of roughly 16.7 points. This would mean that the mean QOL reported for this sample will be accurate to within 1 point on the 0--100 point scale.

Covariates considered in this study can be broadly grouped into demographic (age, gender, race, comorbidities), social (employment status, marital status, years of education), smoking history (pack years, never, former, recent quitter, still smoking) disease-related (histology, stage, grade), and treatment-related (chemotherapy, radiation, surgery) characteristics. Smoking classification was assessed in several ways. First was pack years, defined as the number of packs of cigarettes smoked over time. For example, a participant who smoked one pack of cigarettes per day for 20 years, would have a 20 year pack history. Participants were also classified according to smoking status at the time they completed the survey packet: never smoker (less than 100 life time cigarettes), former smoker (quit more than 12 months), recent quitter (quit more than 30 days but less than 12 months), or current smoker (any tobacco usage in the past 30 days).

Model Building included Cox proportional hazards models (forward and backward stepping, saturated, and stepwise approaches) for relating exercise to survival while controlling for the covariates listed above. Cluster analysis was employed to identify correlated symptoms and treatment/disease status, thus reduce dimensionality of the numerous covariate influences that arose from the survival models.

Results {#Sec3}
=======

Demographics and clinical data are summarized in Table [1](#Tab1){ref-type="table"} for the 1466 lung cancer survivors comprising our sample. Survivors ranged in age from 18 to 93 years of age with an average age of 66 years (SD = 11 years). The sample was equally divided between the genders and 93 % of the sample was Caucasian. Over 90 % graduated high school and the majority was married (78 %). Follow-up ranged as long as 9 years but averaged 3 years, and 35 % of the possible study participants were dead at the time of study follow-up. Smoking behavior past or present was prevalent (83 %) although 17 % of the lung cancer survivors reported that they had never smoked. For those that smoked the average pack years was 47 years. Roughly half of the survivors had advanced stage disease at the time of observation. Treatment prevalence rates were 61, 54, and 33 % for surgery, chemotherapy and radiotherapy respectively.Table 1Participant characteristics for 1466 lung cancer survivors by Baecke physical activity dataParticipant characteristicNon-physically active (*N* = 331)Physically active (*N* = 1135)Total (*N* = 1466)Age at diagnosis  *N*33111351466 Mean (SD)68.7 (9.73)64.9 (10.82)65.7 (10.7) Range(35.0--91.0)(18.0--93.0)(18--93)Gender Female158 (47.7 %)568 (50 %)726 (49.5 %) Male173 (52.3 %)567 (50 %)740 (50.5 %)Race Caucasian311 (94 %)1059 (93.3 %)1370 (93.5 %) Hispanic4 (1.2 %)8 (0.7 %)12 (0.8 %) Alaskan/Indian15 (4.5 %)54 (4.8 %)69 (4.7 %) Black1 (0.3 %)3 (0.3 %)4 (0.3 %) Asian/Pacific Islander0 (0.0 %)6 (0.5 %)6 (0.4 %) Unknown0 (0.0 %)5 (0.4 %)5 (0.3 %)Years of schooling completed N67307374 Mean (SD)13.0 (2.35)13.6 (2.41)13.5 (2.4) Range(6.0--17.0)(5.0--18.0)(5.0--18.0)Marital status Missing62185247 Single9 (3.3 %)47 (4.9 %)56 (4.6 %) Married194 (72.1 %)751 (79.1 %)945 (77.5 %) Divorced27 (10 %)75 (7.9 %)102 (8.4 %) Widowed39 (14.5 %)75 (7.9 %)114 (9.4 %) Life partner0 (0.0 %)2 (0.2 %)2 (0.2 %)Vital status (as of 2/2010) Alive167 (50.5 %)787 (69.3 %)954 (65.1 %) Dead164 (49.5 %)348 (30.7 %)512 (34.9 %)Time to last FU (as of 2/2010) in years N33111351466 Mean (SD)2.7 (2.15)3.3 (2.43)3.1 (2.38) Range(0.1--8.6)(0.0--9.0)2.2Cigarette smoking status Never36 (10.9 %)218 (19.2 %)254 (17.3 %) Former smoker165 (49.8 %)615 (54.2 %)780 (53.2 %) Current smoker129 (39 %)294 (25.9 %)423 (28.9 %) Some smoking history1 (0.3 %)8 (0.7 %)9 (0.6 %)Pack-Years N2929101202 Mean (SD)53.2 (34.44)45.4 (28.29)47.3 (30.07) Range(0.5--208.0)(0.0--180.0)(0.0--208.0)Condensed grade Missing167 1 = Well differentiated58 (17.6 %)328 (29.1 %)386 (26.5 %) 2 = Moderately differentiated104 (31.5 %)414 (36.7 %)518 (35.5 %) 3 = Poorly differentiated142 (43 %)321 (28.4 %)463 (31.7 %) 4 = Non-gradeable26 (7.9 %)66 (5.8 %)92 (6.3 %)Stage Missing6511 Limited27 (8.3 %)36 (3.2 %)63 (4.3 %) Extensive22 (6.8 %)30 (2.7 %)52 (3.6 %) Stage IA49 (15.1 %)320 (28.3 %)369 (25.4 %) Stage IB48 (14.8 %)186 (16.5 %)234 (16.1 %) Stage IIA6 (1.8 %)24 (2.1 %)30 (2.1 %) Stage IIB17 (5.2 %)68 (6 %)85 (5.8 %) Stage IIIA42 (12.9 %)124 (11 %)166 (11.4 %) Stage IIIB45 (13.8 %)116 (10.3 %)161 (11.1 %) Stage IV69 (21.2 %)226 (20 %)295 (20.3 %)T (tumor) of TNM staging Missing69176245 No primary tumor6(2.3 %)10(1.0 %)16(1.3 %) Tumor \< = 3 cm83 (31.7 %)420 (43.8 %)503 (41.2 %) Tumor \> 3 cm92 (35.1 %)309 (32.2 %)401 (32.8 %) Invades chest wall14 (5.3 %)54 (5.6 %)68 (5.6 %) Invades mediastinum56 (21.4 %)137 (14.3 %)193 (15.8 %) Cannot be assessed11 (4.2 %)29 (3 %)40 (3.3 %)N (nodes) of TNM staging Missing51123174 No nodal mets122 (43.6 %)611 (60.4 %)733 (56.7 %) In Peribr/Hilar30 (10.7 %)98 (9.7 %)128 (9.9 %) In Medias/Subcarinal97 (34.6 %)210 (20.8 %)307 (23.8 %) Mets in contralaterl22 (7.9 %)76 (7.5 %)98 (7.6 %) Nodes Unassessable9 (3.2 %)17 (1.7 %)26 (2 %)Surgery Missing122739 No179 (56.1 %)381 (34.4 %)560 (39.2 %) Yes140 (43.9 %)727 (65.6 %)867 (60.8 %)Surgery within 6 months Missing122739 No189 (59.2 %)435 (39.3 %)624 (43.7 %) Yes130 (40.8 %)673 (60.7 %)803 (56.3 %)Chemotherapy Missing122739 No120 (37.6 %)542 (48.9 %)662 (46.4 %) Yes199 (62.4 %)566 (51.1 %)765 (53.6 %)Chemotherapy within 6 months Missing122739 No166 (52 %)686 (61.9 %)852 (59.7 %) Yes153 (48 %)422 (38.1 %)575 (40.3 %)Radiation Missing122739 No193 (60.5 %)769 (69.4 %)962 (67.4 %) Yes126 (39.5 %)339 (30.6 %)465 (32.6 %)Radiation within 6 months Missing122739 No230 (72.1 %)875 (79 %)1105 (77.4 %) Yes89 (27.9 %)233 (21 %)322 (22.6 %)

Physical activity level of survivors was dichotomized as physically active or not physically active by the readiness to change scale as described above. The majority (77 %) of the 1466 patients who provided a physical activity classification (6 out of the original 1472 patients did not) reported themselves as being in the action stage for physical activity based on this classification. The individual item results for the Baecke activity questionnaire are given in Table [2](#Tab2){ref-type="table"}. Survivors who were physically active reported significantly different results for almost all of the individual Baecke items. Almost 62 % of the patients were retired, while 28 % identified themselves as being employed. Roughly 45 % of patients reported they participated regularly in sports or exercise an average of 6 h per week. Roughly half of the survivors indicated that they thought they participated in sport activity less than others. Over three quarters of the survivors reported that they engaged in cycling on at least a semi-regular basis. Roughly 15 % (208 out 1427) of patients changed their level of physical activity over time.Table 2Individual Baecke item overall distributions by physical activity levelNon-physically active (*N* = 331)Physically active (*N* = 1135)Total (*N* = 1466)*p* valueRetired\<0.0001^\*^ Missing68153221 No56 (21.3 %)421 (42.9 %)477 (38.3 %) Yes207 (78.7 %)561 (57.1 %)768 (61.7 %)Employed\<0.0001^\*^ Missing4610 No285 (87.2 %)757 (67.1 %)1042 (71.6 %) Yes42 (12.8 %)372 (32.9 %)414 (28.4 %)At work - sit0.0003^\*^ Missing2837421025 Never1 (2.1 %)24 (6.1 %)25 (5.7 %) Seldom0 (0 %)57 (14.5 %)57 (12.9 %) Sometimes7 (14.6 %)105 (26.7 %)112 (25.4 %) Often27 (56.3 %)129 (32.8 %)156 (35.4 %) Always/Very Often13 (27.1 %)78 (19.8 %)91 (20.6 %)At work - stand Missing2897451034 Never14 (33.3 %)39 (10.0 %)53 (12.3 %) Seldom28 (66.7 %)126 (32.3 %)154 (35.6 %) Sometimes0 (0 %)140 (35.9 %)140 (32.4 %) Often0 (0 %)85 (21.8 %)85 (19.7 %)At work - walk\<0.0001^\*^ Missing2867451031 Never15 (33.3 %)35 (9.0 %)50 (11.5 %) Seldom30 (66.7 %)117 (30.0 %)147 (33.8 %) Sometimes0 (0 %)166 (42.6 %)166 (38.2 %) Often0 (0 %)72 (18.5 %)72 (16.6 %)At work - lift0.2175^\*^ Missing3148601174 Never12 (66.7 %)138 (50.2 %)150 (51.4 %) Seldom5 (33.3 %)81 (29.5 %)86 (29.5 %) Sometimes0 (0 %)42 (15.3 %)42 (14.4 %) Often0 (0 %)14 (5.1 %)14 (4.8 %)At work - sweat0.0160^\*^ Missing3078511158 Never14 (58.3 %)113 (39.8 %)127 (41.2 %) Seldom10 (41.7 %)95 (33.5 %)105 (34.1 %) Sometimes0 (0 %)60 (21.1 %)60 (19.5 %) Often0 (0 %)16 (5.6 %)16 (5.2 %)After work - tired0.0694^\*^ Missing2847421026 Never3 (6.4 %)37 (9.4 %)40 (9.1 %) Seldom12 (25.5 %)155 (39.4 %)167 (38.0 %) Sometimes15 (31.9 %)122 (31.0 %)137 (31.1 %) Often17 (36.2 %)79 (20.1 %)96 (21.8 %)Work compared to others0.0009^\*^ Missing2857341019 Much heavier1 (2.2 %)26 (6.5 %)27 (6.0 %) Heavier3 (6.5 %)50 (12.5 %)53 (11.9 %) As heavy12 (26.1 %)155 (38.7 %)167 (37.4 %) Lighter19 (41.3 %)131 (32.7 %)150 (33.6 %) Much lighter11 (23.9 %)39 (9.7 %)50 (11.2 %)Sports or exercise\<0.0001^\*^ Missing152035 No316 (100 %)459 (41.2 %)775 (54.2 %) Yes0 (0 %)656 (58.8 %)656 (45.8 %)Second sport or exercise\<0.0001^\*^ Missing275479754 No56 (100 %)436 (66.5 %)492 (69.1 %) Yes0 (0 %)220 (33.5 %)220 (30.9 %)Sport activity compared to others\<0.0001^\*^ Missing6384147 Much more0 (0 %)72 (6.9 %)72 (5.5 %) More0 (0 %)221 (21.0 %)221 (16.8 %) The Same36 (13.4 %)345 (32.8 %)381 (28.9 %) Less97 (36.2 %)272 (25.9 %)369 (28.0 %) Much Less135 (50.4 %)141 (13.4 %)276 (20.9 %)Comparison based on frequency0.0057^\*^ Missing202511713 No8 (6.2 %)10 (1.6 %)18 (2.4 %) Yes121 (93.8 %)614 (98.4 %)735 (97.6 %)Comparison based on intensity0.2262^\*^ Missing242740982 No11 (12.4 %)33 (8.4 %)44 (9.1 %) Yes78 (87.6 %)362 (91.6 %)440 (90.9 %)Comparison based on duration0.5282^\*^ Missing231746977 No9 (9.0 %)28 (7.2 %)37 (7.6 %) Yes91 (91.0 %)361 (92.8 %)452 (92.4 %)Leisure - sweat\<0.0001^\*^ Missing205575 Very often0 (0 %)55 (5.1 %)55 (4.0 %) Often0 (0 %)133 (12.3 %)133 (9.6 %) Sometimes94 (30.2 %)345 (31.9 %)439 (31.6 %) Seldom119 (38.3 %)364 (33.7 %)483 (34.7 %) Never98 (31.5 %)183 (16.9 %)281 (20.2 %)Leisure - Yard or housework\<0.0001^\*^ Missing171734 Very often0 (0 %)355 (31.8 %)355 (24.8 %) Often0 (0 %)433 (38.7 %)433 (30.2 %) Sometimes176 (56.1 %)211 (18.9 %)387 (27.0 %) Seldom60 (19.1 %)77 (6.9 %)137 (9.6 %) Never78 (24.8 %)42 (3.8 %)120 (8.4 %)Leisure - watch TV\<0.0001^\*^ Missing92332 Very often118 (36.6 %)206 (18.5 %)324 (22.6 %) Often96 (29.8 %)415 (37.3 %)511 (35.6 %) Sometimes82 (25.5 %)381 (34.3 %)463 (32.3 %) Seldom13 (4.0 %)97 (8.7 %)110 (7.7 %) Never13 (4.0 %)13 (1.2 %)26 (1.8 %)Leisure - walk\<0.0001^\*^ Missing172239 Very often9 (2.9 %)166 (14.9 %)175 (12.3 %) Often28 (8.9 %)355 (31.9 %)383 (26.8 %) Sometimes122 (38.9 %)390 (35.0 %)512 (35.9 %) Seldom106 (33.8 %)166 (14.9 %)272 (19.1 %) Never49 (15.6 %)36 (3.2 %)85 (6.0 %)Leisure - bicycle\<0.0001^\*^ Missing276693 Very often1 (0.3 %)24 (2.2 %)25 (1.8 %) Often4 (1.3 %)55 (5.1 %)59 (4.3 %) Sometimes14 (4.6 %)148 (13.8 %)162 (11.8 %) Seldom37 (12.2 %)186 (17.4 %)223 (16.2 %) Never248 (81.6 %)656 (61.4 %)904 (65.8 %)Leisure - Walk/bike minutes per day\<0.0001^\*\*^ N171695866 Mean (SD)6.9 (15.1)18.7 (32.7)16.3 (30.4) Median0.010.05.0 Q1, Q30.0, 10.00.0, 30.00.0, 30.0 Range(0--120)(0--600)(0--600)^\*^Chi-square test, ^\*\*^Wilcoxon

Co-morbidities and cancer stage impact on physical activity indicated that patients with co-morbidities were more likely to not be physically active versus those who did not have co-morbidities (23 % versus 18 %, *p* = 0.14 respectively). Similarly, patients with early stage disease were more likely to be physically active than those with late stage disease (83 % versus 72 %, *p* \< .001 respectively).

Lung cancer treatment impact on physical activity is provided in Table [3](#Tab3){ref-type="table"}. Participants who were physically active were more likely to be surgical patients than receiving chemotherapy or radiation (43, 11 and 11 %, respectively). Similarly, more of the surgical patients (87 %) were physically active than for the other treatments (73 %) For survivors who had multiple treatments, 14 % of patients changed in the degree of physical activity level after 1 year.Table 3Treatment type by physical activity levelNon-physically active (*N* = 331)Physically active (*N* = 1135)Total (*N* = 1466)*p* valueTreatment\<0.0001^\*^ Missing122739 Surgery alone90 (6.3 %)490 (34.3 %)580(40.6 %) Chemo or radio alone75 (5.3 %)155 (10.9 %)230 (16.1 %) Surgery and chemo or radio29 (2.0 %)121 (8.5 %)150(10.5 %) Chemo plus radio67 (4.7 %)161 (11.3 %)228 (16.0 %) Other58 (4.1 %)181 (12.7 %)239 (16.8 %)^\*^Chi-square test

Lung cancer survivor-reported QOL indicated the benefits of physical activity in all domains (Table [4](#Tab4){ref-type="table"}). Overall QOL and physical QOL differed by more than 15 points on a 0--100 point scale, roughly equivalent to one standard deviation, a huge effect size. Emotional and mental well-being differed by roughly 9 points, larger than a clinically meaningful effect size of 50 % times the standard deviation. Lung cancer survivors who were physically active also reported less pain frequency, pain severity, dry coughing, coughing with phlegm, SOB, and fatigue.Table 4Quality of life by physical activity levelNon-physically active (*N* = 331)Physically active (*N* = 1135)Total (*N* = 1466)*p* value^\*^Emotional well being\<0.0001  *N*29910151314 Mean (SD)69.3 (22.1)77.8 (19.4)75.9 (20.3) Deficiency (\<=50)92 (30.8 %)150 (14.8)Physical well being\<0.0001  *N*29910151314 Mean (SD)54.2 (22.9)70.8 (20.2)67.1 (21.9) Deficiency (\<=50)166 (55.5 %)229 (22.6 %)Mental well being\<0.0001  *N*29910161315 Mean (SD)71.7 (21.70)80.1 (18.5)78.2 (19.6) Deficiency (\<=50)82 (27.4 %)120 (11.8 %)Overall QOL\<0.0001  *N*29910141313 Mean (SD)59.3 (23.3)75.6 (18.8)71.9 (21.1) Deficiency (\<=50)140 (46.2 %)161 (16.0 %)Frequency of pain\<0.0001  *N*29610131309 Mean (SD)57.0 (30.5)67.4 (29.1)65.0 (29.7) Deficiency (\<=50)145 (49.0 %)339 (33.5 %)Severity of pain\<0.0001  *N*29610141310 Mean (SD)61.4 (27.1)72.7 (24.7)70.2 (25.7) Deficiency (\<=50)129 (43.6 %)258 (25.4 %)Frequency of dry coughing0.0035  *N*29910161315 Mean (SD)67.0 (27.3)71.7 (27.2)70.6 (27.3) Deficiency (\<=50)96 (32.1 %)273 (26.9 %)Frequency of coughing with phlegm\<0.0001  *N*29710111308 Mean (SD)67.3 (29.4)75.6 (26.8)73.7 (27.6) Deficiency (\<=50)102 (34.3 %)228 (22.5 %)Shortness of breath\<0.0001  *N*29910181317 Mean (SD)46.9 (27.7)59.5 (27.4)56.6 (28.0) Deficiency (\<=50)191 (63.9 %)448 (44.0 %)Level of fatigue\<0.0001  *N*29910181317 Mean (SD)39.6 (23.1)53.9 (24.3)50.7 (24.8) Deficiency (\<=50)227 (75.9 %)555 (54.5 %)^\*^Wilcoxon

Physical activity by time until death analysis indicated that patients who were within 6 months of death less active than patients who were 6 months to a year, versus more than a year away from death (72, 76, 78 % respectively and *p* = 0.80).

Disease recurrence rates were the same whether the patients reported being physically active (81 %) or not physically active (82 %) (Chi-square test *p* = 0.62). Overall survival however was profoundly different as seen in Fig. [1](#Fig1){ref-type="fig"} with those who were physically active surviving an average of 4 more years than those who were not physically active (8.4 years versus 4.4 years respectively, logrank *p* \< 0.0001). The impact of being physically active on survival was consistent across disease stage (early versus late, Fig. [2](#Fig2){ref-type="fig"}) and type of lung cancer (Non-Small Cell Lung Cancer (NSCLC) vs. Small Cell Lung Cancer (SCLC), Fig. [3](#Fig3){ref-type="fig"}). When covariates (age at diagnosis, gender, race, disease stage, treatment, smoking status, and pack years) were added to the survival analysis via a Cox regression model, the hazard ratio for non-physically active patients to physically active patients was 1.29 (Table [5](#Tab5){ref-type="table"}, 95 % CI =1.00 to 1.67, *p* = 0.05).Fig. 1Kaplan-Meier survival curves for lung cancer survivors by level of physical activityFig. 2Kaplan-Meier survival curves for lung cancer survivors by stage of disease (early vs late)Fig. 3Kaplan-Meier survival curves for lung cancer survivors by type of lung cancer (Non-Small Cell Lung Cancer(NSCLC) vs Small Cell Lung Cancer(SCLC))Table 5Cox regression modelParameterHazard ratio95 % hazard ratio confidence limits*P* valueNon physically active1.2941.0031.6690.0472Age at diagnosis1.0191.0071.0310.0021Female0.8280.6621.0350.0976Surgery alone0.4140.2830.606\<.0001Chemo or radio alone2.3331.6653.268\<.0001Surgery and chemo or radio0.7280.4681.1340.1602Chemo plus radio1.4631.0272.0850.0353Never smoker0.8900.6201.2790.5292Former smoker1.0620.8241.3690.6418Overall QOL0.9920.9870.9980.0057Fatigue0.9920.9850.9980.0094Coughing1.0020.9971.0070.4913Shortness of breath1.0030.9981.0080.2170Pain0.9970.9921.0010.1594Stage I0.3290.2260.479\<.0001Stage II0.4050.2500.6560.0002Stage III/Limited0.5510.4190.726\<.0001

Cluster analysis of the nine potentially important variables (Fig. [4](#Fig4){ref-type="fig"}) indicated that two clusters formed readily related to symptoms (pain, fatigue, cough, shortness of breath, physical active status) and to treatment/disease status (treatment type, disease stage, smoking status). Cluster analysis/logistic regression indicated that the first characteristic differentiating active patients from inactive patients was fatigue, followed by pain, treatment, age at diagnosis and smoking status. Collectively these five items accounted for 19 % of the variance in physical activity.Fig. 4Cluster dendogram for lung cancer survivors

Discussion {#Sec4}
==========

This large prospective epidemiological study of lung cancer survivors provides further support for the premise that being physical active is beneficial to both quality and quantity of life. Virtually all QOL domains studied indicated clinically meaningful advantages for lung cancer survivors reporting being physically active versus those who were not physically active.

These findings are consistent with previous literature in that the benefits of being active for lung cancer survivors are similar to those for the general population. The differences were profound in terms of the effect size benefit for those who are physically active. Recent studies of the most prevalent and concerning symptoms among cancer patients indicate that similar to our patients, fatigue, pain and insomnia are major impacts on the QOL of lung cancer patient survivors. Smoking continues to be a profound indicator of well-being for cancer patients. The results are also consistent with our previous work on the prognostic power of overall QOL on the survival of lung cancer patients30 in that it highlights a natural linkage between physical activity, health promotion behavior, and QOL which together in turn contribute to the quality and quantity of survival in patients with lung cancer.

This report provides new information regarding the specific issues facing lung cancer survivors. Encouragingly, the majority of lung cancer survivors do remain physically active. The deficits observed however are specific to lung cancer and different from those expressed by breast cancer survivors for example. Further, this study identified that physical activity in general was related to the level of symptoms experienced and the type of treatments received. In particular, surgical patients can be expected to be more likely to be physically active because they are likely to be earlier stage and less ill than other patients.

This study has limitations in that it is an observational rather than a controlled experimental layout. There could be concomitant influences alongside the physical activity reporting that could account for the majority of the apparent impact. For example, performance status and stage of disease could play a role in determining if a person is physically active or not. This is unlikely the case in this study however, because even once these covariates had been included in the survival model, the significance of the physical activity level remained.

Further, it is acknowledged that obtaining accurate measures of physical activity is challenging. In this study we encountered a major barrier in the quality of the data returned for the Baecke questionnaire. Presumably in previous validation studies, participants were given the questionnaire in the presence of study assistants who could help them answer the relatively complex and involved questions of the Baecke questionnaire. Nonetheless, we were able to analyze the individual items and saw that the results were amazingly consistent for all 16 questions. Future research is needed to make this challenging task easier for patients and scientists to obtain accurate and consistent estimates of physical activity, especially since the impact of physical activity has demonstrated to have potentially profound impact on patient well-being.

Conclusion {#Sec5}
==========

Some recent work described the ability to integrate objective measures in large cohort design, the future studies should employ objective measures of physical activity, such as the accelerometry \[[@CR40], [@CR41]\].

LCSS

:   Lung Cancer Symptom Scale

NCCTG

:   North Central Cancer treatment Group

QOL

:   quality of life
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